↓ Skip to main content

Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System Perspective

Overview of attention for article published in BMC Health Services Research, November 2015
Altmetric Badge

Mentioned by

twitter
2 X users

Readers on

mendeley
93 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System Perspective
Published in
BMC Health Services Research, November 2015
DOI 10.1186/s12913-015-1139-y
Pubmed ID
Authors

M. Charokopou, P. McEwan, S. Lister, L. Callan, K. Bergenheim, K. Tolley, R. Postema, R. Townsend, M. Roudaut

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 1%
Unknown 92 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 19 20%
Student > Postgraduate 10 11%
Other 9 10%
Student > Ph. D. Student 9 10%
Researcher 8 9%
Other 8 9%
Unknown 30 32%
Readers by discipline Count As %
Medicine and Dentistry 32 34%
Pharmacology, Toxicology and Pharmaceutical Science 15 16%
Economics, Econometrics and Finance 5 5%
Business, Management and Accounting 3 3%
Biochemistry, Genetics and Molecular Biology 2 2%
Other 4 4%
Unknown 32 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 November 2015.
All research outputs
#17,776,579
of 22,832,057 outputs
Outputs from BMC Health Services Research
#6,290
of 7,638 outputs
Outputs of similar age
#192,084
of 285,414 outputs
Outputs of similar age from BMC Health Services Research
#105
of 132 outputs
Altmetric has tracked 22,832,057 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,638 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.7. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 285,414 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 132 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.